Inventor · disambiguated record
Andrew Frederick Wilks
Also filed as: WILKS ANDREW F · WILKS ANDREW FREDERICK · WILKS ANDREW W
35 granted patents·18 pending applications·533 citations·filing 1991–2015
98Inventor score
Files withLUDWIG INST CANCER RES11CYTOPIA RES PTY LTD5WILKS ANDREW F5YM BIOSCIENCES AUSTRALIA PTY5VEGENICS LTD4
Top patents by PatentIndex Score
53 records- 0196US6235713B1Vascular endothelial growth factor-D (VEGF-D) polypeptidesLUDWIG INST CANCER RES·Filed 1997·Granted May 22, 2001·113 cites·16 claims
- 0295US8486941B2Phenyl amino pyrimidine compounds and uses thereofBURNS CHRISTOPHER JOHN·Filed 2008·Granted Jul 16, 2013·80 cites·17 claims
- 0394US7593820B2Crystal structure of human Janus Kinase 2 (JAK2) and uses thereofCYTOPIA RES PTY LTD·Filed 2005·Granted Sep 22, 2009·78 cites·5 claims
- 0494US7122654B2Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of useUNIV HELSINKI LICENSING·Filed 2002·Granted Oct 17, 2006·33 cites·1 claims
- 0593US7785803B2Antibody diagnostic kits and methods of useVEGENICS LTD·Filed 2007·Granted Aug 31, 2010·14 cites·6 claims
- 0693US6689580B1Growth factorLUDWIG INST CANCER RES·Filed 1999·Granted Feb 10, 2004·59 cites·14 claims
- 0792US7410639B2Vascular endothelial growth factor D(VEGF-D) antibodies and methods of useVEGENICS LTD·Filed 2002·Granted Aug 12, 2008·25 cites·33 claims
- 0889US7928061B2Methods of using VEGF-D polypeptidesVEGENICS PTY LTD·Filed 2007·Granted Apr 19, 2011·6 cites·15 claims
- 0987US7662932B2Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of useVEGENICS LTD·Filed 2007·Granted Feb 16, 2010·6 cites·3 claims
- 1086US7511047B2Kinase inhibitorsCYTOPIA RES PTY LTD·Filed 2006·Granted Mar 31, 2009·8 cites·9 claims
- 1185US7871798B2Mammalian cells that express VEGF-D polypeptidesVEGENICS LTD·Filed 2007·Granted Jan 18, 2011·3 cites·13 claims
- 1285US7598272B2Kinase inhibitorsCYTOPIA RES PTY LTD·Filed 2006·Granted Oct 6, 2009·7 cites·11 claims
- 1384US8227410B2Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D)ACHEN MARC G·Filed 2011·Granted Jul 24, 2012·4 cites·12 claims
- 1483US9238628B2Phenyl amino pyrimidine compounds and uses thereofYM BIOSCIENCES AUSTRALIA PTY·Filed 2013·Granted Jan 19, 2016·5 cites·2 claims
- 1580US7259179B2Kinase inhibitorsCYTOPIA RES PTY LTD·Filed 2003·Granted Aug 21, 2007·12 cites·11 claims
- 1677US8084456B2Pyrazine-based tubulin inhibitorsBURNS CHRISTOPHER JOHN·Filed 2003·Granted Dec 27, 2011·14 cites·15 claims
- 1776US8329737B2Benzimidazoles as selective kinase inhibitorsSTYLES MICHELLE LEANNE·Filed 2010·Granted Dec 11, 2012·6 cites·4 claims
- 1876US7122550B2Protein kinase inhibitorsCYTOPIA PTY LTD·Filed 2003·Granted Oct 17, 2006·13 cites·11 claims
- 1975US8394806B22-phenyl pyrazines as tubulin inhibitorsBURNS CHRISTOPHER JOHN·Filed 2011·Granted Mar 12, 2013·2 cites·3 claims
- 2073US9139560B2Substituted pyrazines as tubulin inhibitorsYM BIOSCIENCES AUSTRALIA PTY·Filed 2014·Granted Sep 22, 2015·1 cites·3 claims
- 2167US7795206B2Peptide that inhibits janus kinaseYM BIOSCIENCES AUSTRALIA PTY L·Filed 2006·Granted Sep 14, 2010·2 cites·6 claims
- 2266US8759286B2Pharmaceutical compositions comprising a VEGF-D polypeptideVEGENICS PTY LTD·Filed 2013·Granted Jun 24, 2014·0 cites·5 claims
- 2366US7981900B22-phenyl pyrimidines which are tubulin inhibitorsYM BIOSCIENCES AUSTRALIA PTY·Filed 2004·Granted Jul 19, 2011·2 cites·14 claims
- 2466US2008145366A1Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of useLICENTIA LTD·Filed 2007·Application pending·0 cites
- 2565US9233934B2Phenyl amino pyrimidine compounds and uses thereofYM BIOSCIENCES AUTRALIA PTY LTD·Filed 2013·Granted Jan 12, 2016·1 cites·5 claims
- 2663US2006177428A1Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of useUNIV HELSINKI LICENSING·Filed 2005·Application pending·0 cites
- 2762US8445234B2Methods of making VEGF-D polypeptidesACHEN MARC G·Filed 2012·Granted May 21, 2013·0 cites·6 claims
- 2862US7737143B2Substituted pyrazines as kinase inhibitorsYM BIOSCIENCES AUSTRALIA PTY L·Filed 2004·Granted Jun 15, 2010·2 cites·12 claims
- 2960US2004175730A1Vascular endothelial growth factor D(VEGF-D) antibodies and vectors, and methods of useLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
- 3059US5658791AAntibodies which specifically bind to proteins having tyrosine kinase activity, wherein said proteins have more than one tyrosine kinase domain, and no SH2 domainsLUDWIG INST CANCER RES·Filed 1995·Granted Aug 19, 1997·9 cites·9 claims
- 3159US2007161635A1Kinase inhibitorsBURNS CHRISTOPHER J·Filed 2007·Application pending·0 cites
- 3258US9732046B2Substituted 1,2,4-triazines as tubulin inhibitorsYM BIOSCIENCES AUSTRALIA PTY·Filed 2015·Granted Aug 15, 2017·0 cites·4 claims
- 3358US2013274263A1Tubulin inhibitorsYM BIOSCIENCES AUSTRALIA PTY·Filed 2013·Application pending·0 cites
- 3458US2007276607A1Crystal structure and uses thereofWILKS ANDREW F·Filed 2007·Application pending·0 cites
- 3558US2007136006A1Crystal structure and uses thereofWILKS ANDREW F·Filed 2007·Application pending·0 cites
- 3658US2007136005A1Crystal structure and uses thereofWILKS ANDREW F·Filed 2007·Application pending·0 cites
- 3758US2007129896A1Crystal structure and uses thereofWILKS ANDREW F·Filed 2007·Application pending·0 cites
- 3855US2007129895A1Crystal structure and uses thereofWILKS ANDREW F·Filed 2007·Application pending·0 cites
- 3954US2021309615A1Phenyl amino pyrimidine compounds and uses thereofYM BIOSCIENCES AUSTRALIA PTY LTD C/O GILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
- 4050US2006148824A1Protein kinase inhibitorsBURNS CHRISTOPHER J·Filed 2006·Application pending·0 cites
- 4150US2006069084A1Methods of inhibiting kinasesBURNS CHRISTOPHER J·Filed 2005·Application pending·0 cites
- 4248US5902584AAntibodies which bind the G-CSF receptor extracelluar domain and methods of treatmentLUDWIG INST CANCER RES·Filed 1995·Granted May 11, 1999·10 cites·28 claims
- 4348US5821069AMethod for determining tyrosine kinase in a sampleLUDWIG INST CANCER RES·Filed 1997·Granted Oct 13, 1998·7 cites·6 claims
- 4447US5716818AProtein tyrosine kinaseLUDWIG INST CANCER RES·Filed 1995·Granted Feb 10, 1998·4 cites·14 claims
- 4547US2008207613A1Selective Kinase InhibitorsCYTOPIA RES PTY LTD·Filed 2005·Application pending·0 cites
- 4647US2004102455A1Method of inhibiting kinasesFiled 2002·Application pending·0 cites
- 4738US2004142404A1Protein kinase signallingFiled 2002·Application pending·0 cites
- 4837US5910426AProtein tyrosine kinaseLUDWIG INST CANCER RES·Filed 1998·Granted Jun 8, 1999·2 cites·7 claims
- 4936US5852184AProtein tyrosine kinaseLUDWIG INST CANCER RES·Filed 1991·Granted Dec 22, 1998·2 cites·5 claims
- 5035US6107472AReceptor-type tyrosine kinase-like moleculesLUDWIG INST CANCER RES·Filed 1993·Granted Aug 22, 2000·3 cites·12 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →